| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0919bef0c14ed4fc07ca190cacd30281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77188f6124dd0a00e5ca427b1e9f61b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06880aaeba9a219db892e3604ab58d3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d46ba3b046f99f1264fbcb6c297f26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e54944520d92321e475b90b1a43e623e |
| publicationDate |
2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120117954-A |
| titleOfInvention |
Heat shock protein binding compounds, compositions, and methods of making and using the same |
| abstract |
The subject matter is a compound represented by formula (I) or (I ') or a pharmaceutically acceptable salt thereof; Pharmaceutical compositions containing at least one of these compounds; Methods of making at least one of these compounds; Methods of treating and / or preventing various cancers and / or proliferative disorders using at least one of these compounds; At least one of these compounds relates to methods of using to monitor the effectiveness of anticancer therapies for various cancers. In one embodiment, the subject matter relates to a compound that binds to a specific level of heat shock protein 70 (Hsp70). In another embodiment, the subject matter relates to a compound that binds with a level of specificity that inhibits both heat shock protein 70 (Hsp70) and heat shock receptor protein 70 (Hsc70). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170005095-A |
| priorityDate |
2009-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |